These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36871188)

  • 1. Cytokines in New-Onset Refractory Status Epilepticus Predict Outcomes.
    Hanin A; Cespedes J; Dorgham K; Pulluru Y; Gopaul M; Gorochov G; Hafler DA; Navarro V; Gaspard N; Hirsch LJ
    Ann Neurol; 2023 Jul; 94(1):75-90. PubMed ID: 36871188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
    Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
    Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
    Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
    Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-proteomic Analysis Revealed Distinct Protein Profiles in Cerebrospinal Fluid of Patients Between Anti-NMDAR Encephalitis NORSE and Cryptogenic NORSE.
    Wang D; Wu Y; Pan Y; Wang S; Liu G; Gao Y; Xu K
    Mol Neurobiol; 2023 Jan; 60(1):98-115. PubMed ID: 36224320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuronal antibodies in cryptogenic new onset refractory status epilepticus.
    Eisele A; Schwager M; Bögli SY; Reichen I; Dargvainiene J; Wandinger KP; Imbach L; Haeberlin M; Keller E; Jelcic I; Galovic M; Brandi G
    Epilepsia; 2023 Dec; 64(12):e229-e236. PubMed ID: 37607299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-line immunotherapy in new onset refractory status epilepticus.
    Hanin A; Muscal E; Hirsch LJ
    Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
    J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data.
    Nabbout R; Matricardi S; De Liso P; Dulac O; Oualha M
    Front Neurol; 2023; 14():1134827. PubMed ID: 37122314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NORSE seasonality may vary geographically in adults.
    Bolle AE; Gaist T; Kuljis AME; Blaabjerg M; Beier CP
    Epilepsia Open; 2024 Jun; 9(3):1088-1095. PubMed ID: 38635008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The seasonality of new-onset refractory status epilepticus (NORSE).
    Gopaul MT; Hanin A; Cespedes J; Pulluru Y; Kazazian K; van Baalen A; Gofton TE; Gaspard N; Hirsch LJ
    Epilepsia; 2023 Jun; 64(6):e112-e117. PubMed ID: 37013696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries.
    Kazazian K; Kellogg M; Wong N; Eschbach K; Moeller RF; Gaspard N; Hirsch LJ; Hocker S; Gofton T
    Epilepsy Curr; 2021 Mar; ():1535759721998329. PubMed ID: 33663265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
    Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
    Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
    Carson R; Stredny CM
    Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
    Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
    Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rat hippocampus section immunostaining an indicator for immunotherapy in cryptogenic adult new-onset refractory status epilepticus (NORSE)?
    Wang D; Pan Y; Huang K; Lin Z; Xie Z; Liu G; Wu Y; Wang S
    Seizure; 2020 Feb; 76():131-136. PubMed ID: 32066091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
    Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
    PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.